{
  "ticker": "LXEO",
  "company_name": "Lexeo Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06109181",
      "title": "Gene Therapy for ACM Due to a PKP2 Pathogenic Variant",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC",
      "start_date": "2024-02-29",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT05445323",
      "title": "Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Friedreich Ataxia, Cardiomyopathy, Secondary",
      "start_date": "2022-08-24",
      "completion_date": "2029-09",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT07050160",
      "title": "Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "",
      "condition": "Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC",
      "start_date": "2025-08-29",
      "completion_date": "2030-08",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT06976606",
      "title": "A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC",
      "start_date": "2024-01-23",
      "completion_date": "2027-09",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT05400330",
      "title": "Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Alzheimer Disease",
      "start_date": "2023-05-08",
      "completion_date": "2028-11",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT06865482",
      "title": "Clinical Course Of Disease In Participants With FA-CM",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Friedreich Ataxia, Cardiomyopathy",
      "start_date": "2025-09-30",
      "completion_date": "2027-09",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    },
    {
      "nct_id": "NCT03634007",
      "title": "Gene Therapy for APOE4 Homozygote of Alzheimer's Disease",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Alzheimer Disease, Early Onset Alzheimer Disease",
      "start_date": "2019-11-06",
      "completion_date": "2024-11-07",
      "enrollment": 0,
      "sponsor": "Lexeo Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1, PHASE2": 3,
      "": 3,
      "PHASE1": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 3,
      "ENROLLING_BY_INVITATION": 1,
      "RECRUITING": 2,
      "COMPLETED": 1
    },
    "active_trials": 6,
    "completed_trials": 1,
    "conditions": [
      "Alzheimer Disease",
      "Alzheimer Disease, Early Onset Alzheimer Disease",
      "Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC",
      "Friedreich Ataxia, Cardiomyopathy",
      "Friedreich Ataxia, Cardiomyopathy, Secondary"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:46.463984",
    "search_query": "Lexeo Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Lexeo+Therapeutics,+Inc."
  }
}